Efficacy of Zidovudine Compared to Stavudine, Both in Combination with Lamivudine and Indinavir, in Human Immunodeficiency Virus-Infected Nucleoside-Experienced Patients with No Prior Exposure to Lamivudine, Stavudine, or Protease Inhibitors (Novavir Trial)

We compared the efficacy and the toxicity of zidovudine (AZT) versus stavudine (d4T), in combination with lamivudine (3TC) and indinavir, in AZT-, dideoxyinosine (ddI)-, and/or dideoxycytosine (ddC)-experienced patients in a randomized comparative multicenter trial. One hundred seventy human immunod...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Joly, Véronique, Flandre, Philippe, Meiffredy, Vincent, Brun-Vezinet, Françoise, Gastaut, Jean-Albert, Goujard, Cécile, Remy, Gérard, Descamps, Diane, Ruffault, Annick, Certain, Agnès, Aboulker, Jean-Pierre, Yeni for the Novavir Study Group, Patrick
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC127263/
https://ncbi.nlm.nih.gov/pubmed/12019107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1906-1913.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars